These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20662250)

  • 1. [Protective immunity against Mycobacterium tuberculosis].
    Kawamura I
    Kekkaku; 2010 Jun; 85(6):539-46. PubMed ID: 20662250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in understanding of the virulence mechanism of Mycobacterium tuberculosis].
    Kawamura I
    Nihon Hansenbyo Gakkai Zasshi; 2008 Sep; 77(3):219-24. PubMed ID: 18800644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protective immunity against Mycobacterium tuberculosis].
    Kawamura I
    Kekkaku; 2006 Nov; 81(11):687-91. PubMed ID: 17154048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
    Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of toll-like receptor 2 in survival strategies of Mycobacterium tuberculosis in macrophage phagosomes.
    Yoshida A; Inagawa H; Kohchi C; Nishizawa T; Soma G
    Anticancer Res; 2009 Mar; 29(3):907-10. PubMed ID: 19414326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes.
    Bonecini-Almeida MG; Chitale S; Boutsikakis I; Geng J; Doo H; He S; Ho JL
    J Immunol; 1998 May; 160(9):4490-9. PubMed ID: 9574555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages.
    Rengarajan J; Bloom BR; Rubin EJ
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8327-32. PubMed ID: 15928073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in human neutrophils by Mycobacterium tuberculosis is dependent on mature bacterial lipoproteins.
    Persson A; Blomgran-Julinder R; Eklund D; Lundström C; Stendahl O
    Microb Pathog; 2009 Sep; 47(3):143-50. PubMed ID: 19501642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant M. smegmatis vaccine targeted delivering IL-12/GLS into macrophages can induce specific cellular immunity against M. tuberculosis in BALB/c mice.
    Yi Z; Fu Y; Yang C; Li J; Luo X; Chen Q; Zeng W; Jiang S; Jiang Y; He Y; Yang J; Liu Y; Li N; Zhu DY
    Vaccine; 2007 Jan; 25(4):638-48. PubMed ID: 17000035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection.
    Salgame P
    Curr Opin Immunol; 2005 Aug; 17(4):374-80. PubMed ID: 15963709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nontuberculous mycobacteriosis; the present status and in the future. Mechanisms of host resistance to Mycobacterium avium complex and Mycobacterium tuberculosis infection].
    Tomioka H; Sato K; Shimizu T; Akaki T
    Kekkaku; 1998 Feb; 73(2):71-6. PubMed ID: 9545699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mycobacterium tuberculosis virulence factors and its immune evasion mechanisms].
    Colakoğlu S
    Mikrobiyol Bul; 2004; 38(1-2):155-67. PubMed ID: 15293916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.
    McKinney JD; Höner zu Bentrup K; Muñoz-Elías EJ; Miczak A; Chen B; Chan WT; Swenson D; Sacchettini JC; Jacobs WR; Russell DG
    Nature; 2000 Aug; 406(6797):735-8. PubMed ID: 10963599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances in tuberculosis immunity].
    Akagawa KS
    Kekkaku; 2012 Feb; 87(2):61-70. PubMed ID: 22514942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune control of tuberculosis by IFN-gamma-inducible LRG-47.
    MacMicking JD; Taylor GA; McKinney JD
    Science; 2003 Oct; 302(5645):654-9. PubMed ID: 14576437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isocitrate lyase from Mycobacterium tuberculosis promotes survival of Mycobacterium smegmatis within macrophage by suppressing cell apoptosis.
    Li JM; Li N; Zhu DY; Wan LG; He YL; Yang C
    Chin Med J (Engl); 2008 Jun; 121(12):1114-9. PubMed ID: 18706230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection.
    Palendira U; Spratt JM; Britton WJ; Triccas JA
    Vaccine; 2005 Feb; 23(14):1680-5. PubMed ID: 15705472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human macrophage host defense against Mycobacterium tuberculosis.
    Liu PT; Modlin RL
    Curr Opin Immunol; 2008 Aug; 20(4):371-6. PubMed ID: 18602003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.